04.21.25 -- Deal And Investment Trends And Risks

In the 100th episode of Cell & Gene: The Podcast, Erin Harris interviews Audrey Greenberg, Founder and CEO of AG Capital Advisors. They discuss the challenges and opportunities in CGT biotech, the funding crisis, the evolving investment landscape, and the sustainability of the traditional VC model. Audrey also shares insights on scaling biotech companies, the role of AI in drug discovery, leadership in biotech, and empowering diverse voices and women leaders in CGT. Listen now!

Discover how Redbud Labs is revolutionizing sample preparation with cutting-edge microfluidics technology and their innovative platform that enhances laboratory efficiency.

As recombinant protein-based products accelerate toward IND, reliable process development methods are critical to meet demand. Review case studies to learn how expedited timelines can be achieved.

Prepaid debit cards have revolutionized participant payments in clinical trials. However, questions are being raised about transparency and who sets fees.

Explore key challenges in accessing and preparing analytics-ready clinical data, how FAIR guiding principles can help maximize the value of clinical trial data, and the impact of innovative analytics.

The 43rd annual J.P. Morgan Healthcare Conference featured presentations from a host of large, medium, and small-cap life sciences companies that discussed past performance and future outlooks.